An experimental drug slowed triple-negative breast cancer in mice by flooding tumour cells with toxic fats. Triple-negative breast cancer lacks three common drug targets, making it...
Cervical cancer elimination in the EU is becoming achievable as HPV vaccination coverage rises, a new report says. As Europe marks European Immunisation Week 2026, the...
An independent meta-analysis from January 2026, pooling 2,117 patients and 2,176 Magseed marker placements, has reported low re-excision rates (8.2%) and low positive margins (7.6%) when...
Poor mental health, poverty and pollution can raise women’s heart failure risk, with up to one in four cases potentially preventable, a study has found. UK...
GSK said its ovarian cancer drug shrank or cleared tumours in more than 60 per cent of patients in an early trial as CCO Luke Miels...
Article produced in association with Spital Clinic Cervical screening saves thousands of lives from cervical cancer in the UK every year. The programme has changed significantly...
Australian startup Proseek Bio has raised AU$1.5m in an oversubscribed seed round to commercialise its ovarian cancer blood test. With up to 80 per cent of...
The Femtech World Awards are celebrating the innovators revolutionising the way we diagnose and treat cancer in women. Cancer is a major public health and economic...
More than three million cells have been mapped, showing how breast tissue changes with age, with the biggest shifts seen during menopause. The research, described as...
HRT patches used for menopause may be as effective as injections at preventing prostate cancer spread, a study suggests. Patches that lower testosterone by delivering oestradiol,...
